✦ LIBER ✦

Outcomes after differential use of drug-eluting stents in diabetic patients: 1-Year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry

✍ Scribed by Ibrahim Akin; Alexander Bufe; Lars Eckardt; Holger Reinecke; Gert Richardt; Karl-Heinz Kuck; Jochen Senges; Steffen Schneider; Christoph A. Nienaber; for the DES.DE Study group

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 384 KB
Volume: 76
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.22450

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcomes of drug-eluting stent

Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: Results from the Prairie “Real World” Stent Registry

✍ Nilesh J. Goswami; Matthew Gaffigan; Gadiel Berrio; Anna L. Plessa; Amanda M. Pf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

Long-term clinical benefit of drug-eluti

Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry

✍ Davide Capodanno; Maria Elena Di Salvo; Tullio Palmerini; Imad Sheiban; Massimo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Outcome of patients treated by a novel t

Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry

✍ Francesco Burzotta; Carlo Trani; Daniel Todaro; Mario Attilio Mazzari; Italo Por 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

Economic outcomes of percutaneous corona

Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial

✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery